Your browser doesn't support javascript.
Treatment for Immune Thrombocytopenia in Coronavirus Disease 2019 (COVID-19) Infection after COVID-19 Vaccination: A Case Report.
Lee, Jun Hee; Oh, Sang-Min; Lee, Eunyoung; Bang, Ji Hwan; Park, Sang-Won.
  • Lee JH; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Oh SM; Division of Infectious Diseases, Seoul National University Hospital, Seoul, Korea.
  • Lee E; Division of Infectious Diseases, Seoul National University Boramae Medical Center, Seoul, Korea. eunylee0903@gmail.com.
  • Bang JH; Division of Infectious Diseases, Seoul National University Boramae Medical Center, Seoul, Korea.
  • Park SW; Division of Infectious Diseases, Seoul National University Boramae Medical Center, Seoul, Korea.
Infect Chemother ; 54(3): 559-562, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2055540
ABSTRACT
Thrombocytopenia is one of the rare signs of both the coronavirus disease 2019 (COVID-19) and COVID-19 vaccination. An 85-year-old man was diagnosed with immune thrombocytopenia and COVID-19, 7 days after COVID-19 vaccination. The patient was successfully treated with a short course of intravenous immunoglobulin and oral corticosteroids.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines Language: English Journal: Infect Chemother Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines Language: English Journal: Infect Chemother Year: 2022 Document Type: Article